News Release


Basic Memorandum of Understanding to Co-develop the Anti-Fungal Agent PEKIRON Nail lacquer

November 27, 2001

Kyorin Pharmaceutical Co., Ltd. (Head office: Tokyo, President: Ikuo Ogihara) and Maruho Co., Ltd (Head office: Osaka, President: Koichi Takagi) have signed a Basic Memorandum of Understanding to co-develop in Japan the anti-fungal agent PEKIRON® nail lacquer currently under development by Kyorin Pharamceutical.

The Basic Memorandum of Understanding represents a joint meeting of interests, with Kyorin Pharmaceutical seeking faster development of PEKIRON® nail lacquer in Japan and Maruho's desire to build a development pipeline to strengthen its dermatology field.

Get Adobe Acrobat Reader

Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.